{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:15:29Z","timestamp":1785842129602,"version":"3.56.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/igc.0b013e318244cedc","type":"journal-article","created":{"date-parts":[[2012,3,7]],"date-time":"2012-03-07T07:43:15Z","timestamp":1331106195000},"page":"599-606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Incidence and Survival Trends of Uncommon Corpus Uteri Malignancies in the Netherlands, 1989\u20132008"],"prefix":"10.1016","volume":"22","author":[{"given":"Dorry","family":"Boll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob H.A.","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike A.","family":"van der Aa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Pauwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike E.","family":"Karim-Kos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem W.","family":"Coebergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena C.","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e318244cedc_bb0005","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0010","author":"Online Cancer Registry"},{"key":"10.1097\/IGC.0b013e318244cedc_bb0015","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ejca.2008.11.003","article-title":"The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis","volume":"45","author":"De Angelis","year":"2009","journal-title":"Eur J Cancer."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0020","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0025","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/bjc.2011.68","article-title":"Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006","volume":"104","author":"Evans","year":"2011","journal-title":"BrJ Cancer."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0030","series-title":"Pathology and Genetics of Tumours of the Breast and Female Genital Organs","author":"Tavassoli","year":"2003"},{"key":"10.1097\/IGC.0b013e318244cedc_bb0035","series-title":"TNM Atlas","author":"Hermanek","year":"1997"},{"key":"10.1097\/IGC.0b013e318244cedc_bb0040","first-page":"369","article-title":"Completeness of cancer registration in Limburg","volume":"22","author":"Schouten","year":"1993","journal-title":"The Netherlands. Int JEpidemiol."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0045","unstructured":"Wittekind C, Klimfinger M, Sobin LH. UICC global cancer control. In: TNM Atlas. Springer Medizin Verlag. ISBN 3\u2013540-63799\u20130."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0050","unstructured":"Kurman RJ. Blaustein\u2019s Pathology of the Female Genital Tract. Springer ISBN 0\u2013387-95203\u20139."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/sim.1597","article-title":"Regression models for relative survival","volume":"23","author":"Dickman","year":"2004","journal-title":"Stat Med."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1006\/gyno.1994.1207","article-title":"Uterine papillary serous carcinoma revisited","volume":"54","author":"Hendrickson","year":"1994","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0065","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ygyno.2004.07.021","article-title":"The classification of a uterine sarcoma as \u2018high-grade endometrial stromal sarcoma\u2019 should be abandoned","volume":"95","author":"Amant","year":"2004","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0070","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1006\/gyno.1995.9957","article-title":"Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 cases","volume":"59","author":"Kato","year":"1995","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/gyno.1994.1208","article-title":"Uterine papillary serous carcinoma: patterns of metastatic spread","volume":"54","author":"Goff","year":"1994","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0080","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/cncr.24247","article-title":"Platinum\/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma","volume":"115","author":"Fader","year":"2009","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0085","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ygyno.2009.07.030","article-title":"An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)","volume":"115","author":"Fader","year":"2009","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0090","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ygyno.2007.01.041","article-title":"Outcomes in surgical stage I uterine papillary serous carcinoma","volume":"105","author":"Havrilesky","year":"2007","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0095","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2009.06.011","article-title":"Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review","volume":"115","author":"Boruta","year":"2009","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00125480-200405000-00001","article-title":"Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects","volume":"11","author":"Clement","year":"2004","journal-title":"Adv Anat Pathol."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00000478-199004000-00002","article-title":"The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohistochemical study","volume":"14","author":"Bitterman","year":"1990","journal-title":"Am JSurg Pathol."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0110","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<424::AID-PATH949>3.0.CO;2-L","article-title":"Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed mullerian tumours","volume":"183","author":"Abeln","year":"1997","journal-title":"J Pathol."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine sarcomas: a review","volume":"116","author":"D\u2019Angelo","year":"2010","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0120","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(00)02677-5","article-title":"Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres\u2019 ALERT Group. Assessment protocol of liver and endometrial cancer risk following tamoxifen","volume":"356","author":"Bergman","year":"2000","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e318244cedc_bb0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10549-007-9823-1","article-title":"Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer","volume":"112","author":"Hoogendoorn","year":"2008","journal-title":"Breast Cancer Res Treat."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24088443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24088443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:17:46Z","timestamp":1753222666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24088443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1048891X24088443"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e318244cedc","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Survival Trends of Uncommon Corpus Uteri Malignancies in the Netherlands, 1989\u20132008","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e318244cedc","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2012 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}